Tag: Jack Elias
SEC filing of the week: Ocean Biomedical faces loss of licensing...
PROVIDENCE – Ocean Biomedical Inc. is facing the termination of licensing agreements for technologies developed at Brown University and Rhode Island Hospital.
In its filing...
SEC filing of the week: Ocean Biomedical posts $8.42M loss in...
PROVIDENCE – Ocean Biomedical Inc. reported a loss of $8.42 million in the first quarter compared with a profit of $13 million the biopharmaceutical company...
SEC filing of the week: Ocean Biomedical expands into energy, digital...
PROVIDENCE – Ocean Biomedical Inc. is expanding into the energy and digital-asset sectors while announcing it has been delisted on the Nasdaq Stock Market...
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M...
PROVIDENCE – Ocean Biomedical Inc. ended 2024 with a loss of $9.4 million compared to the $114.4 million deficit the company reported the year...
New CEO, several board members to step down from Ocean Biomedical
PROVIDENCE – Four out of nine members of Ocean Biomedical Inc.'s board of directors, including the new CEO, are stepping down amidst a larger...
Ocean Biomedical faces Nasdaq delisting
PROVIDENCE – Ocean Biomedical Inc. is at risk of being kicked off the Nasdaq exchange for failing to file quarterly and other required financial...
- Featured Event -
